Therapeutic plasma exchange, which aims to treat systemic sclerosis (SSc) by clearing the blood of antibodies, cytokines and other factors…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
Severe malnutrition significantly decreases the quality of life of patients with systemic sclerosis (SSc), according to researchers. Standardized nutritional…
It takes more than three years for half of Britons with rheumatic diseases like scleroderma, lupus and vasculitis to obtain…
Implanting some of scleroderma patients’ fat cells in their fingers significantly improved their hand function and overall disability, a clinical…
Myeloablative Stem Cell Transplant Improves Long-term Outcomes in Severe Scleroderma, Trial Shows
Immunosuppressive therapy followed by an autologous stem cell transplant resulted in significant long-term benefits, including improved overall survival, in adult…
New research establishes a link between immune cells, known as macrophages, and systemic sclerosis progression. The study showed that gene…
Newly ID’d Gene Variant Linked to Slower Progression of Systemic Sclerosis in Women in Small Study
A newly discovered genetic variant in the FOXP3 gene is associated with a slower progression of systemic sclerosis in women,…
75% of Scleroderma Patients Show Meaningful Skin Improvement with Anabasum, Extension Study Shows
The thick skin that is a hallmark of scleroderma showed meaningful improvement in 75 percent of patients treated with Corbus…
Viracept (nelfinavir mesylate, NFV), an antiretroviral drug approved as a therapy against the human immunodeficiency virus (HIV), could be beneficial…
High levels of a cytokine called CCL2 circulating in the blood can predict how quickly and severely lung disease will…